MAPT and Alzheimer disease: Studies have confirmed that there are obvious phosphorylation modifications of Thr181, Thr231, Ser235, Tyr394, Ser396, and Ser404 in the Tau protein in the brain of AD patients, which suggested that the protein was closely associated with neurodegeneration [26].